Tag: STEMI

ESC 2017: Further decreasing mortality after STEMI will be difficult

According to results from the FAST-MI programme, six-month mortality after ST-segment elevation myocardial infarction (STEMI) and after non-STEMI (NSTEMI) considerably decreased between 1995 and...

The ATI score: A new tool to triage novel treatments in...

Mechanical reperfusion via primary percutaneous coronary intervention (PCI) in combination with optimised antithrombotic therapy and antiplatelet therapy is the current gold-standard treatment for ST-segment...

Performing PCI in comatose survivors of cardiac arrest

Because of a significant improvement in the prehospital treatment of patients with out-of-hospital cardiac arrest, an increasing number of resuscitated, comatose patients are being...

Infection in the setting of STEMI

The association between infections and acute coronary syndromes has been the subject of interest for many years. Recent evidence demonstrates an increased risk of...

CADILLAC risk score could be used to identify STEMI patients for...

Musa A Sharkawi (Department of Cardiovascular Medicine, Hartford Hospital, Hartford, USA) and others report in Catheterization and Cardiovascular Interventions that the CADILLAC risk score...

Smartphones can help to streamline hospital transfer for myocardial infarction patients

A study published, as a research letter, in the Journal of the American College of Cardiology indicates that smartphone communication among medical teams at...

ESC 2016: Off-hours STEMI patients do not have worse outcomes

A new analysis of data from the CHAMPION PHOENIX (Cangrelor versus standard therapy to achieve optimal management of platelet inhibition) trial, published in the...

ESC 2016: Drug-eluting stents are still preferred despite no long-term survival...

The results of NORSTENT (Norwegian coronary stent trial) indicate that second-generation drug-eluting stents do not significantly reduce the long-term risk of all-cause mortality compared...